Evidence map›Paper›PMID 17301807›Full record

ArticleLeukemia2007

Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia.

C-H Pui, D Campana

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in Leukemia, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. MLL fusions: pathways to leukemia.Cancer biology & therapy · 2009
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

C-H Pui
D Campana

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDRENR01CA078224 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SPARREBOOM, ALEXANDER · 1998 to 2007
$3.6M
P450 METABOLISM OF EPIPODOPHYLLOTOXINS IN CHILDRENR01CA051001 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI RELLING, MARY V. · 1996 to 2006
$2.7M
DETECTION AND THERAPY OF RESIDUAL LEUKEMIA IN CHILDRENR01CA060419 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CAMPANA, DARIO · 1998 to 2006
$1.7M
Clinical Significance of Residual Myeloid LeukemiaR01CA115422 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CAMPANA, DARIO · 2006 to 2010
$1.3M
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDRENR29CA051001 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI RELLING, MARY V. · 1990 to 1994
–
DETECTION OF MINIMAL RESIDUAL LEUKEMIA IN CHILDRENU01CA060419 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CAMPANA, DARIO · 1993 to 1996
–
NCI NIH HHS CA115422NCI NIH HHS CA21765NCI NIH HHS CA51001NCI NIH HHS CA60419NCI NIH HHS CA78224
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgingGene RearrangementHumansLeukemiaMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, FusionPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisMLL-AF4 fusion protein, humanMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, Fusion

Identifiers

PMID17301807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.